Infliximab for the treatment of patients with checkpoint inhibitor–associated acute tubular interstitial nephritis

Acute tubular interstitial nephritis (ATIN) is the most frequently reported pathology in patients with checkpoint inhibitor (CPI) induced acute kidney injury (AKI). Glucocorticoid (GC) therapy and discontinuation of CPI are the mainstay of treatment to prevent permanent renal dysfunction and dialysi...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Oncoimmunology
मुख्य लेखकों: Lin, Jamie S., Mamlouk, Omar, Selamet, Umut, Tchakarov, Amanda, Glass, William F., Sheth, Rahul A., Layman, Rachel M., Dadu, Ramona, Abdelwahab, Noha, Abdelrahim, Maen, Diab, Adi, Yee, Cassian, Abudayyeh, Ala
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Taylor & Francis 2021
विषय:
Brief Report
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC7872057/
https://ncbi.nlm.nih.gov/pubmed/33643693
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2021.1877415
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन